[EN] HYDROXAMIC ACIDS USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS<br/>[FR] ACIDES HYDROXAMIQUES UTILISES POUR TRAITER DES TROUBLES D'HYPERPROLIFERATION
申请人:BAYER PHARMACEUTICALS CORP
公开号:WO2004094376A1
公开(公告)日:2004-11-04
This invention relates to a compound of Formula (I) and its use in treating hyper-proliferative disorders.
这项发明涉及一种式(I)化合物及其在治疗高增殖性疾病中的用途。
[EN] PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME<br/>[FR] DÉRIVÉS BENZÉNIQUES À CHAÎNES ALKYLE ET ALCÉNYLE PÉRIPHÉRIQUES ÉTENDUES ET COMPOSITION PHARMACEUTIQUE COMPRENANT CEUX-CI
申请人:TAIWANJ PHARMACEUTICALS CO LTD
公开号:WO2020205455A1
公开(公告)日:2020-10-08
The compounds represented by Formula (I), which are peripheral alkyl and alkenyl chains extended benzene derivatives, are useful as dual autotaxin (ATX) / histone deacetylase (HD AC) inhibitors. These compounds may be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and be used in a therapeutically effective amount for prophylaxis or treatment of various diseases and disorders.
Hydroxamic acids useful in the treatment of hyper-proliferative disorders
申请人:Wang Yamin
公开号:US20060063760A1
公开(公告)日:2006-03-23
This invention relates to a compound of Formula (I) and its use in treating hyper-proliferative disorders.
本发明涉及一种式(I)的化合物及其在治疗高增殖性疾病中的应用。
Pesticidial Condensed-Ring Aryl Compounds
申请人:Murata Tetsuya
公开号:US20110071141A1
公开(公告)日:2011-03-24
Condensed-ring aryl compounds of formula (I) and use of the same as a agrochemical for controlling noxious organisms wherein (X)
m
Q, A, R
1
, (Y)
n
and the grouping —W
1
—W
2
—W
3
—W
4
— are as defined herein.
PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
申请人:TAIWANJ PHARMACEUTICALS CO., LTD.
公开号:US20220153687A1
公开(公告)日:2022-05-19
The compounds represented by Formula (I), which are peripheral alkyl and alkenyl chains extended benzene derivatives, are useful as dual autotaxin (ATX)/histone deacetylase (HD AC) inhibitors. These compounds may be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and be used in a therapeutically effective amount for prophylaxis or treatment of various diseases and disorders.